MDR 1.23% 40.0¢ medadvisor limited

Investor Newsletter - Issue 3, page-10

  1. 316 Posts.
    lightbulb Created with Sketch. 66

    I think you underestimate the level of competition in the market. Chemist Warehouse has there own medication management solution developed by a Melbourne company. Priceline I think are using the app developed by the Pharmacy Guild. Between these two groups they hold around 1/3rd of the pharmacy market between them. Healthengine have their own too designed to be patient oriented (not pharmacy oriented), but no idea how they plan to commercialise their capability especially in light of there very public meltdown. The consumer numbers that MedAdvisory boast about are actually weak and not strong. Some pivots here are needed in order to accelerate local adoption and monetisation of what they have built. I think part of the problem is that consumers are getting sick of having lots of apps on their phones now. Would not be surprised to see some consolidation of health IT businesses as many are just sub-scale.

    I like the business idea but not the commercial model. I have almost entered it a few times. But remain cautious for the time being.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.